8 results
Original and Simplified PESI Prediction Rule Test Characteristics for 30-Day Mortality
#EBM #Diagnosis	#EM #IM #PCC	#PESI #sPESI #risk
and Simplified PESI ... Day Mortality #EBM ... #IM #PCC #PESI # ... #PE #Sensitivity ... #Specificity #PulmonaryEmbolism
Original and Simplified PESI PulmonaryEmbolism #Diagnosis #EM #IM #PCC #PESI #sPESI #risk #score #PE #Table
and Simplified PESI ... PulmonaryEmbolism ... #Diagnosis #EM ... #IM #PCC #PESI # ... #PE #Table
Long-Term PEITHO Results #EBM #EM #IM #PCC #PEITHO #PE #PulmonaryEmbolism #Embolism #RebelEM
PEITHO Results #EBM ... #EM #IM #PCC #PEITHO ... #PE #PulmonaryEmbolism ... #Embolism #RebelEM
Pulmonary Embolism Severeity Index - estimates 30d mortality #Diagnosis #Management #EM #IM #PCC #PESI #sPESI #risk
Diagnosis #Management #EM ... #IM #PCC #PESI ... #sPESI #risk #score ... #PE #PulmonaryEmbolism
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Fremanezumab for ... to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
The pulmonary embolism rule-out criteria (PERC) was created to reduce testing in patients who have a
probability of PE ... #Diagnosis #EM # ... IM #PERC #Rule # ... Pulmonary #Embolism #PulmonaryEmbolism ... #RebelEM